Metropolitan Life Insurance CO Oyster Point Pharma, Inc. Transaction History

Metropolitan Life Insurance CO

  • $281 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020
SELL
$27.86 - $35.93 $56,054 - $72,291
-2,012 Closed
0 $0
Q1 2020

Jul 12, 2023
BUY
$23.65 - $40.96 $47,583 - $82,411
2,012 New
2,012 $70,000
Q1 2020

Mar 30, 2023
BUY
$23.65 - $40.96 $47,583 - $82,411
2,012 New
2,012 $70,000
Q1 2020

May 15, 2020
BUY
$23.65 - $40.96 $47,583 - $82,411
2,012 New
2,012 $70,000

Others Institutions Holding OYST

# of Institutions
4
Shares Held
19K
Call Options Held
0
Put Options Held
0
View Full List

About Oyster Point Pharma, Inc.

OYST Quotes by TradingView
  • Ticker OYST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,831,500
  • Description
  • Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ophthalmic diseases in the United States. The company's product candidate is TYRVAYA, a nicotinic acetylcholine receptor agonist for the treatment of signs and symptoms of dry ...
More about OYST
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email